bicinchoninic acid has been researched along with 5-[(4-chlorophenyl)methylamino]-6-methyl-2H-1,2,4-triazin-3-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, J; Huang, N; MacKerell, AD; Nagarsekar, A; Xia, G | 1 |
1 other study(ies) available for bicinchoninic acid and 5-[(4-chlorophenyl)methylamino]-6-methyl-2H-1,2,4-triazin-3-one
Article | Year |
---|---|
Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
Topics: Animals; Binding Sites; Cell Survival; Cells, Cultured; Databases, Factual; Enzyme Inhibitors; Humans; Lymphocyte Activation; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Molecular; Molecular Weight; Peptides; Phosphorylation; Spectrometry, Fluorescence; src Homology Domains; Structure-Activity Relationship | 2004 |